Detection and characterization of neurotoxicity in cancer patients using proton MR spectroscopy

Child's Nervous System

Volumn 24, Issue 7, 2008, Pages 807-813

  Steffen Smith, Emilie A ^a   Wolters, Pamela L ^a,b   Albert, Paul S ^c   Baker, Eva H ^c   Shimoda, Kim C ^d   Barnett, Alan S ^e   Warren, Katherine E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Medical Illness Counseling Center   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

MRI; MRS; Neuropsychological assessment; Pediatric; Primary brain tumor

Indexed keywords

ANTINEOPLASTIC AGENT; CREATINE PHOSPHATE; CREATININE; GLYCEROPHOSPHORYLCHOLINE; N ACETYLASPARTIC ACID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; ARITHMETIC; ARTICLE; BRAIN CANCER; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN REGION; CANCER PATIENT; CANCER RADIOTHERAPY; CHILD; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DRUG MEGADOSE; EARLY DIAGNOSIS; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; LONGITUDINAL STUDY; MALE; MEDICAL RESEARCH; MEMORY CONSOLIDATION; MENTAL FUNCTION; NEUROLOGIC DISEASE; NEUROPSYCHOLOGICAL TEST; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; READING; SCORING SYSTEM; WECHSLER INTELLIGENCE SCALE;

ADOLESCENT; ADULT; ASPARTIC ACID; CHILD; CHILD, PRESCHOOL; CHOLINE; CREATINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASMS; NEUROPSYCHOLOGICAL TESTS; NEUROTOXICITY SYNDROMES; PROTONS;

EID: 44649182782     PISSN: 02567040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00381-007-0576-2     Document Type: Article

References (44)

1. Anderson NE (2003) Late complications in childhood central nervous system tumour survivors. Curr Opin Neurol 16(6):677-683, DOI 10.1097/ 00019052-200312000-00006
2. Aydin K, Bakir B, Tatli B, Terzibasioglu E, Ozmen M (2005) Proton MR spectroscopy in three children with Tay-Sachs disease. Pediatr Radiol 35(11):1081-1085, DOI 10.1007/s00247-005-1542-3
3. Bleyer WA, Fallavollita J, Robison L, Balsom W, Meadows A, Heyn R, Sitars A, Ortega J, Miller D, Constine L et al (1990) Influence of age, sex, and concurrent intrathecal methotrexate therapy on intellectual function after cranial irradiation during childhood: A report from the Children's Cancer Study Group. Pediatr Hematol Oncol 7(4):329-338
4. Brown MS, Stemmer SM, Simon JH, Stears JC, Jones RB, Cagnoni PJ, Sheeder JL (1998) White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy. AJNR American J Neuroadiol 19(2):217-221
5. Chen CY, Zimmerman RA, Faro S, Bilaniuk LT, Chou TY, Molloy PT (1996) Childhood leukemia: Central nervous system abnormalities during and after treatment. AJNR Am J Neuroradiol 17(2):295-310
6. Chu W, Chick K, Chan Y, Yeung D, Roebuck D, Howard R, Li C, Metreweli C (2003) White matter and cerebral metabolite changes in children undergoing treatment for acute lymphoblastic leukemia: Longitudinal study with MR Imaging and 1 H-MR Spectroscopy. Radiology 229:659-669, DOI 10.1148/radiol.2293021550
7. Cecil KM, Lenkinski RE (1998) Proton MR spectroscopy in inflammatory and infectious brain disorders. Neuroimaging Clin N Am 8(4):863-880
8. Davidson A, Payne G, Leach MO, McVicar D, Britton JM, Watson M, Tait DM (2000) Proton magnetic resonance spectroscopy ((1)H-MRS) of the brain following high-dose methotrexate treatment for childhood cancer. Med Pediatr Oncol 35(1):28-34
9. Davidson A, Tait DM, Payne GS, Hopewell JW, Leach MO, Watson M, MacVicar AD, Britoon JA, Ashley S (2000) Magnetic resonance spectroscopy in the evaluation of neurotoxicity following cranial irradiation for childhood cancer. Br J Radiol 73(868):421-424
10. Delis DC, Kramer J, Kaplan E, Ober BA (1994) California Verbal Learning Test, Children's Version. Psychological Corporation, San Antonio, TX
11. Delis D, Kramer J, Kaplan E, Ober BA (2000) California Verbal Learning Test, 2nd edn. Psychological Corporation, San Antonio, TX
12. Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CT (1993) Multisection proton MR spectroscopic imaging of the brain. Radiology 188(1):277-282
13. Eiser C, Tillmann V (2001) Learning difficulties in children treated for acute lymphoblastic leukaemia (ALL). Pediatr Rehabil 4(3):105-118, DOI 10.1080/13638490110064806
14. Fayed N, Modrego PJ, Castillo J, Davilla J (2007) Evidence of brain dysfunction in attention deficit-hyperactivity disorder: A controlled study with proton magnetic resonance spectroscopy. Acad Radiol 14(9):1029-1035, DOI 10.1016/j.acra.2007.05.017
15. Garcia-Perez A, Sierrasesumaga L, Narbona-Garcia J, Calvo-Manuel F, Aguirre-Ventallo M (1994) Neuropsychological evaluation of children with intracranial tumors: Impact of treatment modalities. Med Pediatr Oncol 23(2):116-123
16. Hanefeld F, Brockmann K, Dechent P (2005) MR spectroscopy in pediatric white matter disease. In: Gillard J, Waldman A, Barker P (eds) Clinical MR neuroimaging: Diffusion, perfusion, and spectroscopy. Cambridge University Press, Cambridge, U.K., pp 755-778
17. Hunter JV, Thornton RJ, Wang ZJ, Levin HS, Roberson G, Brooks WM, Swank PR (2005) Late proton MR spectroscopy in children after traumatic brain injury: Correlation with cognitive outcomes. AJNR Am J Neuroradiol 26(3):482-488
18. Iuvone L, Mariotti P, Colosimo C, Guzzetta F, Ruggiero A, Riccardi R (2002) Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia. American Cancer Society 95(12):2562-2570
19. Lu D, Pavlakis SG, Frank Y, Bakshi S, Pahwa S, Gould RJ, Sison C, Hsu C, Lesser M, Hoberman M, Barnett T, Hyman RA (1996) Proton MR spectroscopy of the basal ganglia in healthy children and children with AIDS. Radiology 199:423-428
20. McCarthy D (1972) McCarthy Scales of Children's Abilities. Psychological Corporation, San Antonio, TX
21. Magalhaes A, Godfrey W, Shen Y, Hu J, Smith W (2005) Proton magnetic resonance spectroscopy of brain tumors correlated with pathology. Acad Radiol 12(1):51-57
22. Miller BL (1991) A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 4(2):47-52, DOI 10.1016/j.acra.2004.10.057
23. Mulhern RK, Palmer SL, Reddick WE, Glass JO, Kun LE, Taylor J, Langson J, Gajjar A (2001) Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. J Clin Oncol 19(2):472-429
24. Nakayama M, Tavora DG, Alvim TC, Araujo AC, Gama RL (2006) MRI and 1H-MRS findings of three patients with Sjogren-Larsson syndrome. Arq Neuropsiquiatr 64(2B):398-401, DOI 10.1590/S0004-282X2006000300009
25. Nathan PC, Whitcomb T, Wolters PL, Steinberg SM, Balis FM, Brouwers P, Hunsberger S, Feusner J, Sather H, Miser J, Odom LF, Poplack D, Reaman G, Bleyer WA (2006) Very high-dose methotrexate (33.6 g/m2) as CNS preventive therapy for childhood acute lymphoblastic leukemia: Results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P, and CCG-144P. Leuk Lymphoma 47(12):2488-2504
26. Packer RJ, Sutton LN, Atkins TE, Radcliffe J, Bunin GR, D'Angio G, Siegel KR, Schut L (1989) A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-year results. J Neurosurg 70(5):707-713
27. Psychological Corporation (1999) Wechsler Abbreviated Scale of Intelligence. Harcourt Brace, San Antonio, TX
28. Reddick W, Shan Z, Glass J, Helton S, Xiong X, Wu S, Bonner MJ, Howard SC, Christensen R, Khan RB, Pui CH, Mulhern RK (2006) Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Am Cancer Soc 106(4):941-949
29. Reimers TS, Ehrenfels S, Mortensen EL, Schmiegelow M, Sonderkaer S, Cartensen H, Schmiegelow K, Muller J (2003) Cognitive deficits in long-term survivors of childhood brain tumors: Identification of predictive factors. Med Pediatr Oncol 40(1):26-34
30. Reitan R, Davidson L (1974) Clinical Neuropsychology: Current Status and Applications. Wiley, New York
31. Shih MT, Singh AK, Wang AM, Patel S (2004) Brain lesions with elevated lactic acid peaks on magnetic resonance spectroscopy. Curr Probl Diagn Radiol 33(2):85-95, DOI 10.1016/j.cpradiol.2003.11.002
32. Smith JK, Castillo M, Kwock L (2003) MR spectroscopy of brain tumors. Magn Reson Imaging Clin N Am 11(3):415-429, v-vi DOI 10.1016/ S1064-9689(03)00061-8
33. Tedeschi G, Bonavita S (2005) MR spectroscopy in demyelination and inflammation. In: Gillard J, Waldman A, Barker P (eds) Clinical MR Neuroimaging: Diffusion, Perfusion, and Spectroscopy. Cambridge University Press, Cambridge, U.K., pp 429-443
34. Tzika AA, Ball WS Jr., Vigneron DB, Dunn RS, Nelson SJ, Kirks DR (1993) Childhood adrenoleukodystrophy: Assessment with proton MR spectroscopy. Radiology 189(2):467-480
35. Urenjak J, Williams SR, Gadian DG, Noble M (1992) Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 59(1):55-61
36. Waldman AD, Rai GS (2003) The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: A proton magnetic resonance spectroscopy study. Neuroradiology 45(8):507-512, DOI 10.1007/s00234-003-1040-y
37. Warren K, Hill R, Black J, Aikin A, Wolters P, Shimoda K, Balis F (2004) Evaluating Neurotoxicity in Cancer Patients. Neuro-Oncology 6(4):435, (abstract)
38. Wilkinson GS (1993) Wide Range Achievement Test Administration Manual, 3rd edn. Wide Range, Wilmington
39. Wechsler D (1997) Wechsler Adult Intelligence Scale, 3rd edn. Psychological Corporation, San Antonio, TX
40. Wechsler D (1991) Wechsler Intelligence Scale for Children, 3rd edn. Psychological Corporation, San Antonio, TX
41. Wechsler D (1989) Wechsler Preschool and Primary Scale of Intelligence - Revised. Psychological Corporation, San Antonio, TX
42. Willemsen MA, Van Der Graaf M, Van Der Knaap MS, Heerschap A, Van Domburg PH, Gabreels FJ, Rotteveel JJ (2004) MR imaging and proton MR spectroscopic studies in Sjogren-Larsson syndrome: Characterization of the leukoencephalopathy. AJNR Am J Neuroradiol 25(4):649-657
43. Yeo RA, Brooks WM, Jung RE (2006) NAA and higher cognitive function in humans. Adv Exp Med Biol 576:215-226
44. Zaroff CM, Neudorfer O, Morrison C, Pastores GM, Rubin H, Kolodny EH (2004) Neuropsychological assessment of patients with late onset GM2 gangliosidosis. Neurology 62(12):2283-2286